These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 7658719

  • 21. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG.
    Oncogene; 1995 Nov 02; 11(9):1685-92. PubMed ID: 7478595
    [Abstract] [Full Text] [Related]

  • 22. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
    Gross AW, Ren R.
    Oncogene; 2000 Dec 14; 19(54):6286-96. PubMed ID: 11175343
    [Abstract] [Full Text] [Related]

  • 23. v-Abl activates c-myc transcription through the E2F site.
    Wong KK, Zou X, Merrell KT, Patel AJ, Marcu KB, Chellappan S, Calame K.
    Mol Cell Biol; 1995 Dec 14; 15(12):6535-44. PubMed ID: 8524218
    [Abstract] [Full Text] [Related]

  • 24. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.
    Thatikunta P, Raj GV, Kundu M, Khalili K, Amini S.
    Oncogene; 1997 Jun 19; 14(24):2959-69. PubMed ID: 9205103
    [Abstract] [Full Text] [Related]

  • 25. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells.
    Sala A, Nicolaides NC, Engelhard A, Bellon T, Lawe DC, Arnold A, Graña X, Giordano A, Calabretta B.
    Cancer Res; 1994 Mar 15; 54(6):1402-6. PubMed ID: 8137237
    [Abstract] [Full Text] [Related]

  • 26. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
    Good L, Dimri GP, Campisi J, Chen KY.
    J Cell Physiol; 1996 Sep 15; 168(3):580-8. PubMed ID: 8816912
    [Abstract] [Full Text] [Related]

  • 27. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS.
    Oncogene; 2000 Oct 19; 19(44):5054-62. PubMed ID: 11042693
    [Abstract] [Full Text] [Related]

  • 28. Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase.
    Burgess GS, Williamson EA, Cripe LD, Litz-Jackson S, Bhatt JA, Stanley K, Stewart MJ, Kraft AS, Nakshatri H, Boswell HS.
    Blood; 1998 Oct 01; 92(7):2450-60. PubMed ID: 9746785
    [Abstract] [Full Text] [Related]

  • 29. Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line.
    Matulonis U, Salgia R, Okuda K, Druker B, Griffin JD.
    Exp Hematol; 1993 Oct 01; 21(11):1460-6. PubMed ID: 8405226
    [Abstract] [Full Text] [Related]

  • 30. Characterization of cis-regulatory elements of the c-myc promoter responding to human GM-CSF or mouse interleukin 3 in mouse proB cell line BA/F3 cells expressing the human GM-CSF receptor.
    Watanabe S, Ishida S, Koike K, Arai K.
    Mol Biol Cell; 1995 Jun 01; 6(6):627-36. PubMed ID: 7579683
    [Abstract] [Full Text] [Related]

  • 31. The p120-v-Abl protein interacts with E2F-1 and regulates E2F-1 transcriptional activity.
    Birchenall-Roberts MC, Yoo YD, Bertolette DC, Lee KH, Turley JM, Bang OS, Ruscetti FW, Kim SJ.
    J Biol Chem; 1997 Apr 04; 272(14):8905-11. PubMed ID: 9083010
    [Abstract] [Full Text] [Related]

  • 32. p210 bcr-abl confers overexpression of inosine monophosphate dehydrogenase: an intrinsic pathway to drug resistance mediated by oncogene.
    Gharehbaghi K, Burgess GS, Collart FR, Litz-Jackson S, Huberman E, Jayaram HN, Boswell HS.
    Leukemia; 1994 Aug 04; 8(8):1257-63. PubMed ID: 7520100
    [Abstract] [Full Text] [Related]

  • 33. Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells.
    Mandanas RA, Leibowitz DS, Gharehbaghi K, Tauchi T, Burgess GS, Miyazawa K, Jayaram HN, Boswell HS.
    Blood; 1993 Sep 15; 82(6):1838-47. PubMed ID: 7691239
    [Abstract] [Full Text] [Related]

  • 34. BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats.
    Frank DA, Varticovski L.
    Leukemia; 1996 Nov 15; 10(11):1724-30. PubMed ID: 8892675
    [Abstract] [Full Text] [Related]

  • 35. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice.
    Bargou RC, Wagener C, Bommert K, Arnold W, Daniel PT, Mapara MY, Grinstein E, Royer HD, Dörken B.
    J Exp Med; 1996 Mar 01; 183(3):1205-13. PubMed ID: 8642262
    [Abstract] [Full Text] [Related]

  • 36. BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene.
    Sharma N, Magistroni V, Piazza R, Citterio S, Mezzatesta C, Khandelwal P, Pirola A, Gambacorti-Passerini C.
    Mol Cancer; 2015 Jul 16; 14():132. PubMed ID: 26179066
    [Abstract] [Full Text] [Related]

  • 37. The macromolecular state of the transcription factor E2F and glucocorticoid regulation of c-myc transcription.
    Rhee K, Ma T, Thompson EA.
    J Biol Chem; 1994 Jun 24; 269(25):17035-42. PubMed ID: 8006008
    [Abstract] [Full Text] [Related]

  • 38. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
    Hsiao KM, McMahon SL, Farnham PJ.
    Genes Dev; 1994 Jul 01; 8(13):1526-37. PubMed ID: 7958837
    [Abstract] [Full Text] [Related]

  • 39. ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells.
    Tamura T, Kong HJ, Tunyaplin C, Tsujimura H, Calame K, Ozato K.
    Blood; 2003 Dec 15; 102(13):4547-54. PubMed ID: 12933588
    [Abstract] [Full Text] [Related]

  • 40. Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells.
    Melamed D, Tiefenbrun N, Yarden A, Kimchi A.
    Mol Cell Biol; 1993 Sep 15; 13(9):5255-65. PubMed ID: 7689148
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.